top of page

Factor V Mutation (R2 H1299A)

Unravel your risk of blood clots, one gene at a time

  • 15 minutes
  • 125 British pounds
  • 305 Neasden Lane, London NW10 1QR, UK

Service Description

The Factor V gene encodes for Factor V protein, which plays a role in blood clotting. This test uses PCR-Hybridization to detect the R2 H1299A mutation which is a genetic variation in the Factor V gene that has been associated with an increased risk of developing blood clots. The R2 H1299A mutation is relatively rare, but individuals with this mutation may be at increased risk of developing deep vein thrombosis (DVT), pulmonary embolism (PE), and other clotting disorders. The R2 H1299A mutation is inherited in an autosomal dominant pattern, which means that an affected person only needs to inherit one copy of the mutated gene to develop the condition. Testing for the R2 H1299A mutation may be recommended in individuals with a personal or family history of blood clots or unexplained clotting disorders. Individuals who test positive for the mutation may be advised to take steps to reduce their risk of blood clots, such as avoiding smoking, maintaining a healthy weight, and avoiding prolonged periods of immobility. In some cases, individuals with the R2 H1299A mutation may be advised to take anticoagulant medications to reduce their risk of blood clots. However, the decision to take these medications should be made on an individual basis and in consultation with a GP, taking into account the individual's overall health, medical history, and other factors. Sample: BLOOD Results:2 weeks Phlebotomy fee: £15 (included in price)


Cancellation Policy

To cancel or schedule, please contact us 24 hours in advance


Contact Details

  • 305 Neasden Lane, London NW10 1QR, UK

    02071268511

    info@ejbio.co.uk


bottom of page